The American Journal of Cardiovascular Drugs is a leading publication dedicated to promoting rational therapy and effective patient management within the discipline of cardiology. This is achieved through a regular program of independent review articles covering all aspects of cardiovascular disorders management. The journal features:

• Current Opinions and Leading Articles – short overviews of contentious or emerging issues.
• Comprehensive Narrative Reviews – informative articles on therapeutic approaches to managing cardiovascular disease.
• Systematic Reviews – empirical evidence collation to answer specific research questions using explicit, systematic methods.
• Therapy in Practice Reviews – optimum management of specific conditions.
• Adis Drug Reviews – on the properties and place in therapy of newer and established drugs in cardiovascular medicine.
• Original Research Articles – reports of well-designed clinical studies, clinical pharmacodynamic and pharmacokinetic studies, including clinical trials, meta-analyses, outcomes research, and pharmacoeconomic studies.

Additional digital features such as animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts, and animations, can be published with articles to increase the visibility, readership, and educational value of the journal’s content. Furthermore, plain language summaries accompany articles to provide easy understanding of the critical medical advances featured in the journal.

All submissions undergo rigorous peer review by international experts. The journal also encourages letters to the editor, which are welcomed and considered for publication.